[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617110":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":36,"responsibleParty":55,"collaborators":24,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":24,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":24,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":39,"whyStopped":24,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Natural Immune Systems Inc","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental: Crossover group 1, randomized","EXPERIMENTAL","Participants wear an active biofield patch versus a placebo patch for 12 hours on each of the two clinic days, at least 1 week apart, allowing for 1 week wash-out period between each patch. The order of interventions for this group is A, B. Following the blinded phase there will be an open-label phase where participants wear the active patch each day for 1 week until the final clinic visit.",[13,14],"Other: Active dermal patch","Other: Placebo dermal patch",{"label":16,"type":10,"description":17,"interventionNames":18},"Experimental: Crossover group 2, randomized","Participants wear a placebo patch versus an active biofield patch for 12 hours on each of the two clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. The order of interventions for this group is B, A. Following the blinded phase there will be an open-label phase where participants wear the patch each day for 1 week until the final clinic visit.",[13,14],[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Active dermal patch","Non-transdermal patch",[9,16],null,{"type":6,"name":26,"description":22,"armGroupLabels":27,"otherNames":24},"Placebo dermal patch",[9,16],[29,34],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Giite S Jensen, PhD","CONTACT","5418820112","gitte@nislabs.com",{"name":35,"role":31,"phone":24,"phoneExt":24,"email":24},"Alex Cruickshank",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"NIS Labs","RECRUITING","Klamath Falls","Oregon","97601","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-121.78167,42.22487,{"lat":49,"lon":48},[52],{"name":53,"role":31,"phone":32,"phoneExt":24,"email":54},"Gitte S Jensen, PhD","Gitte@nislabs.com",{"type":56,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100617110","rapid-effects-of-a-biofield-patch-on-antioxidant-status-and-cellular-energy-100617110",false,"NCT07314359","Rapid Effects of a Biofield Patch on Antioxidant Status and Cellular Energy","Inclusion Criteria:\n\n* Healthy adults;\n* Age 18 - 75 years (inclusive);\n* BMI between 18.0 and 34.9 (inclusive);\n* Veins easy to see in one or both arms (to allow for the multiple blood draws);\n* Willing to comply with study procedures, including:\n\n  * Maintaining a consistent diet and lifestyle routine throughout the study,\n  * Consistent habit of bland breakfasts on days of clinic visits,\n  * Abstaining from exercising and nutritional supplements on the morning of a study visit,\n  * Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit;\n  * Abstaining from music, candy, gum, computer\u002Fcell phone use (airplane mode is allowed), during clinic visits.\n\nExclusion Criteria:\n\n* Cancer during past 12 months;\n* Chemotherapy during past 12 months;\n* Currently taking prescription weight loss drugs (such as semaglutide);\n* Currently taking cholesterol-lowering medication (for example: statins);\n* Currently experiencing intense stressful events\u002Flife changes;\n* Currently in intensive athletic training (such as marathon runners);\n* Currently taking anxiolytic, hypnotic, or anti-depressant prescription medication;\n* Immunization during past 6 months;\n* An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying);\n* Unwilling to maintain a constant intake of supplements over the duration of the study;\n* Anxiety about having blood drawn;\n* Pregnant, nursing, or trying to become pregnant;\n* Known allergies related to adhesive materials.",true,"ALL","18 Years","75 Years",{"count":68,"type":69},12,"ESTIMATED","INTERVENTIONAL",[72],"NA","The goal for this clinical proof-of-concept study is to compare an active biofield skin patch to a placebo patch on antioxidant function and mitochondrial function. A double-blind, placebo-controlled cross-over study design will be used.",[75],"Antioxidant Status",[77,78,79,80],"Superoxide dismutase activity","Glutathione","Mitochondria","Cytokines","2025-12-17",{"date":83,"type":84},"2026-01-02","ACTUAL",{"date":86,"type":84},"2025-12-04",{"date":88,"type":69},"2026-08",{"name":5,"class":6},1]